The US-based pharmaceutical and baby products company said that the proposed settlement, which still needs the approval of a bankruptcy court, "will equitably and...
Xeris Biopharma Holdings , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapeutic...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced new analyses from the Phase 3 MAIA study of DARZALEX in combination with lenalidomide and...
ANeuroTech, a leader in the development of innovative mental health treatments with minimal or no side effects, announces that following a successful pre-IND meeting,...
Johnson & Johnson announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite Center) at Singapore's Duke-NUS Medical School, jointly...
